BC Extra | Jul 2, 2018
Company News

Dunsire to become Lundbeck CEO

Neurology company H. Lundbeck A/S (CSE:LUN) hired Deborah Dunsire as president and CEO, effective Sept. 1. Dunsire will fill a position that became vacant when Kåre Schultz resigned in September 2017. CFO Anders Götzsche has...
BioCentury | Nov 14, 2017
Regulation

Rules of engagement

An upcoming publication from the National Health Council on good practices for sponsor-patient interactions could help companies overcome fears that their outreach could be construed as promotional. Several executives told BioCentury that having guardrails established...
BC Extra | Mar 8, 2017
Company News

XTuit taps Dunsire as CEO

XTuit Pharmaceuticals Inc. (Waltham, Mass.) hired Deborah Dunsire as president and CEO. Dunsire was most recently president and CEO of Forum Pharmaceuticals Inc. , and is a former president and CEO of the Millennium Pharmaceuticals Inc....
BC Week In Review | Jun 15, 2015
Financial News

Xtuit completes venture financing

Xtuit Pharmaceuticals Inc. , Cambridge, Mass.   Business: Cancer, Hepatic   Date completed: 2015-06-11   Type: Venture financing   Raised: $22 million   Investors: New Enterprise Associates; Polaris Partners; CTI Life Sciences Fund; Arcus Ventures; Omega...
BC Extra | Jun 12, 2015
Financial News

XTuit raises $22 million in series A

XTuit Pharmaceuticals Inc. (Cambridge, Mass.) raised $22 million in a series A round led by New Enterprise Associates. New investors CTI Life Sciences, Arcus Ventures and Omega Funds also participated, as did founding investor Polaris...
Items per page:
1 - 5 of 5
BC Extra | Jul 2, 2018
Company News

Dunsire to become Lundbeck CEO

Neurology company H. Lundbeck A/S (CSE:LUN) hired Deborah Dunsire as president and CEO, effective Sept. 1. Dunsire will fill a position that became vacant when Kåre Schultz resigned in September 2017. CFO Anders Götzsche has...
BioCentury | Nov 14, 2017
Regulation

Rules of engagement

An upcoming publication from the National Health Council on good practices for sponsor-patient interactions could help companies overcome fears that their outreach could be construed as promotional. Several executives told BioCentury that having guardrails established...
BC Extra | Mar 8, 2017
Company News

XTuit taps Dunsire as CEO

XTuit Pharmaceuticals Inc. (Waltham, Mass.) hired Deborah Dunsire as president and CEO. Dunsire was most recently president and CEO of Forum Pharmaceuticals Inc. , and is a former president and CEO of the Millennium Pharmaceuticals Inc....
BC Week In Review | Jun 15, 2015
Financial News

Xtuit completes venture financing

Xtuit Pharmaceuticals Inc. , Cambridge, Mass.   Business: Cancer, Hepatic   Date completed: 2015-06-11   Type: Venture financing   Raised: $22 million   Investors: New Enterprise Associates; Polaris Partners; CTI Life Sciences Fund; Arcus Ventures; Omega...
BC Extra | Jun 12, 2015
Financial News

XTuit raises $22 million in series A

XTuit Pharmaceuticals Inc. (Cambridge, Mass.) raised $22 million in a series A round led by New Enterprise Associates. New investors CTI Life Sciences, Arcus Ventures and Omega Funds also participated, as did founding investor Polaris...
Items per page:
1 - 5 of 5